Searched for
INDIA SPECIALTY PHARMA GROWTH
Fortis Healthcare inks pact with Dion Group for 300-bed hospital in CuttackFortis Healthcare is set to manage and operate a new 300-bed multi-specialty hospital in Cuttack, Odisha, a project valued at Rs 600 crore....- June services growth hits 17-month low as client interest fadesIndia's services sector growth slowed significantly in June, hitting a 17-month low as domestic demand weakened. New business expansion als...
- US, West Asia drag India's pharma exports growthIndian pharmaceutical exports to the US, its largest market, saw a dip in early fiscal months, alongside a slight decline in shipments to W...
- Middle class to remain India’s growth engine: FM SitharamanIndia's middle class is identified as the primary driver of the nation's robust economic expansion, fueling consumption and ensuring its st...
- Assam produces Matcha tea for first time, fetches Rs 3,000 per kg at auctionAssam has officially entered the premium Matcha tea market, with the state's first commercially produced batch fetching an impressive Rs 30...
- Our focus is data centres because they are big fibre guzzlers: Corning's Sudhir PillaiCorning broke ground for a new optical connectivity manufacturing facility in Pune in February this year. The plant is being built alongsid...
- Beyond China, beyond tariffs: India, Japan look to MSMEs to turn strategic ties into factory-floor partnershipsAs Japanese Prime Minister Sanae Takaichi visits India, industry sees the biggest opportunity not in tariff concessions but in supplier eco...
- These large- and mid-cap stocks can give more than 20% return in 1 year, according to analystsIn just a few days, the Q1 earnings season for FY27 will start. But before that will come the season of business updates. And that needs to...
- For low risk-takers: 5 large-caps from different sectors with an upside potential of up to 31%Now, there is nothing wrong with being bullish, because it has always paid to be bullish. Yes, one might argue that it has not paid in the ...
- Cigna invests $100 million in new AI-powered specialty pharmacy programCigna's Evernorth has unveiled Pharmacy Forward, an AI-driven specialty pharmacy program backed by a $100 million investment. This initiati...
- Silent winners! 43 stocks turned multibaggers even as Nifty went nowhere in 2 yearsDespite the Nifty 50 showing minimal returns over two years, astute investors have witnessed significant wealth creation. Forty-three stock...
- Should they now be part of a long-term investing framework? 7 healthcare stocks with upside potential of up to 25%India’s healthcare market may grow steadily, but hospital chains can grow faster as formalisation continues. Healthcare is all about market...
- Avoid expensive themes, focus on valuations and stock picking: Samit VartakIndian equities have rebounded significantly, yet investor sentiment remains cautious due to ongoing geopolitical uncertainties. Despite th...
- Capacity augmentation, value-added applications critical for making India leader in stainless steel productionWith a growing domestic market and potential in sectors like green hydrogen and pharmaceuticals, India aims to be a manufacturing and innov...
- For investors with ability – and patience to wait 3 years, not 3 months: 6 large-cap stocks with upside potential of up to 33%The interesting point about the large-cap space today is not that prices have collapsed. In most cases, they have not. The more important c...
- Healthcare demand is outstripping supply in Noida, says MOFSL; prefers Medanta, Max HealthcareNoida-Greater Noida is rapidly becoming a prime healthcare hub in North India, fueled by population growth and corporate expansion. Despite...
- World MSME Day: Chemical industry seeks policy support to boost competitiveness amid global trade disruptionsIndian chemical industry leaders are urging a policy overhaul to boost competitiveness ahead of World MSME Day 2026. They highlight the nee...
- India Inc profit hit from West Asia tensions to halve if truce holds, Crisil saysCorporate India's profitability impact from the West Asia conflict is now expected to be half of initial fears, with Crisil Ratings predict...
- Pharma, power & mid-sized banks: Where Mayuresh Joshi is putting money to work right nowIndian markets are showing signs of recovery as geopolitical tensions ease, paving the way for a stronger earnings outlook in the second ha...
- India's CDMO industry set for global shift as pharma diversifies beyond China: Sai Life SciencesIndian contract manufacturers are poised for significant growth as global pharmaceutical giants diversify away from China. Companies like S...
Load More
